Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 13, 2017 - Issue
Submit an article Journal homepage
1,666
Views
48
CrossRef citations to date
0
Altmetric
Review

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

Michael Huss1 Child and Adolescent Psychiatry, University Medicine, Mainz, Germany
,
Praveen Duhan2 Global Medical Affairs, Novartis Healthcare Pvt. Ltd., Hyderabad, India
,
Preetam Gandhi3 Development Franchise, Established Medicine Neuroscience, Novartis Pharma AG, Basel, Switzerland
,
Chien-Wei Chen4 Biostatistics Cardio-Metabolic & Established Medicine, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Carsten Spannhuth3 Development Franchise, Established Medicine Neuroscience, Novartis Pharma AG, Basel, Switzerland
&
Vinod Kumar5 Established Medicines, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USACorrespondence[email protected]
Pages 1741-1751 | Published online: 04 Jul 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.